Answers are grounded in this paper and cite their sources.
This analysis critiques real-world evidence claims, suggesting improved transparency through precise terminology.
Although data collected outside traditional RCT are essential to decision-making, the 'real-world' label is a rhetorical construct that obscures study design and introduces an illusion of objective truth. Because all scientific inquiry is limited by the observer's methods, 'real-world' claims are essentially fallacious. To promote transparency, researchers should abandon RWE-related terminology in favor of precise study labelling and explicit disclosures of data source limitations.
No takes yet. Share an insight, caveat, or question.
Zanini et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: